Cultivation service of adipose-derived mesenchymal stem cells used in the clinical trials at the Department of Advanced Medical Initiatives, Kyushu University for evaluating the safety and effectiveness of adipose-derived mesenchymal stem cells against hepatic cirrhosis has started since March 2016.
Patient recruitment was completed in March 2020.